Cognitive impairment is common among adults with heart failure (HF), as both diseases are
strongly related to advancing age and multimorbidity (including both cardiovascular and …

Background While an expanding armamentarium of pharmacologic therapies has
contributed to improved outcomes among adults with heart failure (HF) over the past two …

Heart failure (HF) is a disease with high morbidity and mortality and high impact on function
and quality of life. 1, 2 Although numerous pharmacologic agents have demonstrated …

Objectives: This study sought to describe the patterns of heart failure (HF)-exacerbating
medications used among older adults hospitalized for HF and to examine determinants of …

Background Complex medication regimens, often present in heart failure with preserved
ejection fraction, may increase the risk of adverse drug effects and harm. We sought to …

Background Use of heart failure-exacerbating medications (HFEMs) may lead to
preventable episodes of acute decompensated heart failure (HF). HFEMs use is common in …

Background Heart failure (HF) is a pervasive global health concern, with acute
decompensated heart failure (ADHF) contributing significantly to morbidity and mortality …

Purpose Heart failure is among the leading causes for hospitalization in Europe. In this
study, we evaluate potential precipitating factors for hospitalization for heart failure and …

Study objective Half of patients with heart failure have preserved ejection fraction (HFpEF).
Over the years, guidelines have recommended or advised against various therapies for …

Heart failure (HF) is a serious chronic condition affecting older people globally. In 2016, the
American Heart Association (AHA) highlighted drugs that may cause or exacerbate HF to …